239 related articles for article (PubMed ID: 24002676)
21. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
22. Psoriasis vulgaris does not adversely influence the quality of sleep.
Stinco G; Trevisan G; Piccirillo F; Di Meo N; Nan K; Deroma L; Bergamo S; Patrone P
G Ital Dermatol Venereol; 2013 Dec; 148(6):655-9. PubMed ID: 24442047
[TBL] [Abstract][Full Text] [Related]
23. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
24. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D;
Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in persons living with psoriasis patients.
Martínez-García E; Arias-Santiago S; Valenzuela-Salas I; Garrido-Colmenero C; García-Mellado V; Buendía-Eisman A
J Am Acad Dermatol; 2014 Aug; 71(2):302-7. PubMed ID: 24836080
[TBL] [Abstract][Full Text] [Related]
26. Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity.
Rencz F; Holló P; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Balogh O; Herédi E; Herszényi K; Jókai H; Brodszky V; Gulácsi L
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1398-405. PubMed ID: 25491660
[TBL] [Abstract][Full Text] [Related]
27. Biologics are more potent than other treatment modalities for improvement of quality of life in psoriasis patients.
Takahashi H; Iinuma S; Tsuji H; Honma M; Iizuka H
J Dermatol; 2014 Aug; 41(8):686-9. PubMed ID: 25040258
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in patients with scalp psoriasis.
Zampieron A; Buja A; Fusco M; Linder D; Bortune M; Piaserico S; Baldo V
G Ital Dermatol Venereol; 2015 Jun; 150(3):309-16. PubMed ID: 25236315
[TBL] [Abstract][Full Text] [Related]
29. Internalized stigma in psoriasis: A multicenter study.
Alpsoy E; Polat M; FettahlıoGlu-Karaman B; Karadag AS; Kartal-Durmazlar P; YalCın B; Emre S; Didar-Balcı D; Bilgic-Temel A; Arca E; Koca R; Gunduz K; Borlu M; Ergun T; Dogruk-Kacar S; Cordan-Yazici A; Dursun P; BilgiC O; Gunes-Bilgili S; Sendur N; Baysal O; Halil-Yavuz I; Yagcioglu G; Yilmaz E; Kavuzlu U; Senol Y
J Dermatol; 2017 Aug; 44(8):885-891. PubMed ID: 28407292
[TBL] [Abstract][Full Text] [Related]
30. A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO).
Lambert J; Dowlatshahi EA; de la Brassinne M; Nijsten T
Eur J Dermatol; 2012; 22(2):231-7. PubMed ID: 22266338
[TBL] [Abstract][Full Text] [Related]
31. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis.
Ljosaa TM; Mork C; Stubhaug A; Moum T; Wahl AK
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):29-35. PubMed ID: 21385220
[TBL] [Abstract][Full Text] [Related]
32. How patients experience psoriasis: results from a European survey.
Fouéré S; Adjadj L; Pawin H
J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():2-6. PubMed ID: 16274404
[TBL] [Abstract][Full Text] [Related]
33. Pruritus is an important factor negatively influencing the well-being of psoriatic patients.
Reich A; Hrehorów E; Szepietowski JC
Acta Derm Venereol; 2010 May; 90(3):257-63. PubMed ID: 20526542
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and quality of life of patients with psoriasis in Chile.
Valenzuela F; Silva P; Valdés MP; Papp K
Actas Dermosifiliogr; 2011 Dec; 102(10):810-6. PubMed ID: 21664589
[TBL] [Abstract][Full Text] [Related]
35. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
Fortune DG; Main CJ; O'Sullivan TM; Griffiths CE
Br J Dermatol; 1997 Nov; 137(5):755-60. PubMed ID: 9415236
[TBL] [Abstract][Full Text] [Related]
36. Psoriasis uncovered--measuring burden of disease impact in a survey of Australians with psoriasis.
Baker CS; Foley PA; Braue A
Australas J Dermatol; 2013 Feb; 54 Suppl 1():1-6. PubMed ID: 23379483
[TBL] [Abstract][Full Text] [Related]
37. Perceived stress, stress attributions and psychological distress in psoriasis.
O'Leary CJ; Creamer D; Higgins E; Weinman J
J Psychosom Res; 2004 Nov; 57(5):465-71. PubMed ID: 15581650
[TBL] [Abstract][Full Text] [Related]
38. Physical and psychologic measures are necessary to assess overall psoriasis severity.
Kirby B; Richards HL; Woo P; Hindle E; Main CJ; Griffiths CE
J Am Acad Dermatol; 2001 Jul; 45(1):72-6. PubMed ID: 11423838
[TBL] [Abstract][Full Text] [Related]
39. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study.
Daudén E; Pujol RM; Sánchez-Carazo JL; Toribio J; Vanaclocha F; Puig L; Yébenes M; Sabater E; Casado MA; Caloto MT; Aragón B;
Actas Dermosifiliogr; 2013 Nov; 104(9):807-14. PubMed ID: 23827342
[TBL] [Abstract][Full Text] [Related]
40. Patient benefit index (PBI) in the treatment of psoriasis--results of the National Care Study "PsoHealth".
Radtke MA; Schäfer I; Blome C; Augustin M
Eur J Dermatol; 2013 Apr; 23(2):212-7. PubMed ID: 23587940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
